Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV004590746 | SCV005079212 | pathogenic | not provided | 2023-06-27 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 12453420, 18003757, 32001615, 23274891, 29666556, 34440499, 30455330) |
Prevention |
RCV004731663 | SCV005337672 | likely pathogenic | HNF1A-related disorder | 2024-09-25 | no assertion criteria provided | clinical testing | The HNF1A c.751G>A variant is predicted to result in the amino acid substitution p.Ala251Thr. This variant has been reported in the heterozygous state in multiple individuals with maturity-onset diabetes of the young (MODY) (Thanabalasingham et al. 2013. PubMed ID: 23274891; Pavić et al. 2018. PubMed ID: 29666556). In another study, the variant was reported in the homozygous state in an individuals with young-onset diabetes (teen years), and the heterozygous parents had adult-onset symptoms (Misra et al. 2020. PubMed ID: 32001615). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as likely pathogenic. |